Report cover image

Global Tourette Syndrome Treatment Market Size Study & Forecast, by Product (Antipsychotics, Non-Antipsychotics) and Regional Analysis, 2025-2035

Publisher Bizwit Research & Consulting
Published Dec 02, 2025
Length 285 Pages
SKU # BIZW20613543

Description

The Global Tourette Syndrome Treatment Market is valued at approximately USD 2.37 billion in 2024 and is projected to grow at a CAGR of 6.96% during the forecast period 2025-2035. Tourette Syndrome is a neurological disorder characterized by repetitive, involuntary movements and vocalizations known as tics. Treatments for Tourette Syndrome encompass pharmacological interventions designed to manage tics, enhance quality of life, and reduce associated behavioral complications. The market is primarily driven by the increasing prevalence of neurological disorders, heightened awareness among healthcare professionals and patients, and continuous research in novel therapeutic agents that offer improved efficacy and safety profiles.

Rising clinical recognition and advancements in pharmacotherapy have catalyzed the growth of the Tourette Syndrome Treatment Market. The demand for antipsychotic and non-antipsychotic therapies is escalating due to the need for symptom management and comorbidity mitigation, such as attention-deficit hyperactivity disorder (ADHD) and obsessive-compulsive behaviors. According to recent epidemiological studies, Tourette Syndrome affects approximately 1% of children worldwide, with symptoms often persisting into adulthood. This prevalence, combined with evolving healthcare access and reimbursement mechanisms, offers substantial opportunities for market expansion. Nonetheless, potential side effects of pharmacological interventions and the emergence of non-pharmacological alternatives may temper market growth over the forecast period.

The detailed segments and sub-segments included in the report are:

By Product:
• Antipsychotics
• Non-Antipsychotics

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Antipsychotics Segment Expected to Dominate the Market

Antipsychotics are anticipated to dominate the product segment due to their widespread clinical adoption for tic suppression and behavioral symptom management in Tourette Syndrome patients. These therapies benefit from long-standing clinical validation, extensive physician familiarity, and ongoing development of safer, more targeted agents. Consequently, antipsychotics continue to hold a substantial market share while shaping treatment paradigms globally.

Antipsychotic Treatments Lead in Revenue Contribution

Currently, antipsychotic treatments generate the highest revenue in the market, driven by their efficacy in severe cases and broad adoption across major healthcare systems. Newer formulations and improved dosing regimens further reinforce their revenue dominance. Non-antipsychotic alternatives, while growing in adoption due to favorable safety profiles, currently trail in overall market contribution.

The Global Tourette Syndrome Treatment Market exhibits strong regional variations. North America leads due to advanced healthcare infrastructure, robust neurological research, and favorable reimbursement policies. Europe follows closely, with significant patient awareness and established treatment networks. Asia Pacific is expected to experience the fastest growth, fueled by increasing diagnosis rates, expanding healthcare access, and rising government initiatives to improve neurological care. Latin America and the Middle East & Africa show moderate growth potential, underpinned by expanding awareness campaigns and gradual improvements in healthcare delivery systems.

Major market players included in this report are:
• AbbVie Inc.
• Novartis AG
• UCB S.A.
• Teva Pharmaceutical Industries Ltd.
• Acadia Pharmaceuticals Inc.
• Allergan Plc.
• Lundbeck A/S
• Sun Pharmaceutical Industries Ltd.
• Otsuka Pharmaceutical Co., Ltd.
• GlaxoSmithKline Plc.
• Pfizer Inc.
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• Takeda Pharmaceutical Company Limited
• H. Lundbeck A/S

Global Tourette Syndrome Treatment Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period – 2025-2035
• Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments and countries in recent years and to forecast the values for the coming years. The report incorporates both qualitative and quantitative insights, highlighting growth drivers, market challenges, and emerging opportunities. Additionally, it provides a comprehensive analysis of competitive strategies, key market players, and potential investment avenues across regional micro-markets.

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional-level analysis for each market segment.
• Detailed analysis of the geographical landscape with country-level insights.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of the competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Table of Contents

285 Pages
Chapter 1. Global Tourette Syndrome Treatment Market Report Scope & Methodology
1.1. Research Objective
1.2. Research Methodology
1.2.1. Forecast Model
1.2.2. Desk Research
1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
1.4.1. Market Definition
1.4.2. Market Segmentation
1.5. Research Assumption
1.5.1. Inclusion & Exclusion
1.5.2. Limitations
1.5.3. Years Considered for the Study
Chapter 2. Executive Summary
2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. key Findings
Chapter 3. Global Tourette Syndrome Treatment Market Forces Analysis
3.1. Market Forces Shaping The Global Tourette Syndrome Treatment Market (2024-2035)
3.2. Drivers
3.2.1. increasing prevalence of neurological disorders
3.2.2. heightened awareness among healthcare professionals and patients
3.3. Restraints
3.3.1. Shortage Of Skilled Professionals
3.4. Opportunities
3.4.1. continuous research in novel therapeutic agents
Chapter 4. Global Tourette Syndrome Treatment Industry Analysis
4.1. Porter’s 5 Forces Model
4.1.1. Bargaining Power of Buyer
4.1.2. Bargaining Power of Supplier
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion
Chapter 5. Global Tourette Syndrome Treatment Market Size & Forecasts by Product 2025-2035
5.1. Market Overview
5.2. Global Tourette Syndrome Treatment Market Performance - Potential Analysis (2025)
5.3. Antipsychotics
5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
5.3.2. Market size analysis, by region, 2025-2035
5.4. Non-Antipsychotics
5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
5.4.2. Market size analysis, by region, 2025-2035
Chapter 6. Global Tourette Syndrome Treatment Market Size & Forecasts by Region 2025–2035
6.1. Growth Tourette Syndrome Treatment Market, Regional Market Snapshot
6.2. Top Leading & Emerging Countries
6.3. North America Tourette Syndrome Treatment Market
6.3.1. U.S. Tourette Syndrome Treatment Market
6.3.1.1. Product breakdown size & forecasts, 2025-2035
6.3.2. Canada Tourette Syndrome Treatment Market
6.3.2.1. Product breakdown size & forecasts, 2025-2035
6.4. Europe Tourette Syndrome Treatment Market
6.4.1. UK Tourette Syndrome Treatment Market
6.4.1.1. Product breakdown size & forecasts, 2025-2035
6.4.2. Germany Tourette Syndrome Treatment Market
6.4.2.1. Product breakdown size & forecasts, 2025-2035
6.4.3. France Tourette Syndrome Treatment Market
6.4.3.1. Product breakdown size & forecasts, 2025-2035
6.4.4. Spain Tourette Syndrome Treatment Market
6.4.4.1. Product breakdown size & forecasts, 2025-2035
6.4.5. Italy Tourette Syndrome Treatment Market
6.4.5.1. Product breakdown size & forecasts, 2025-2035
6.4.6. Rest of Europe Tourette Syndrome Treatment Market
6.4.6.1. Product breakdown size & forecasts, 2025-2035
6.5. Asia Pacific Tourette Syndrome Treatment Market
6.5.1. China Tourette Syndrome Treatment Market
6.5.1.1. Product breakdown size & forecasts, 2025-2035
6.5.2. India Tourette Syndrome Treatment Market
6.5.2.1. Product breakdown size & forecasts, 2025-2035
6.5.3. Japan Tourette Syndrome Treatment Market
6.5.3.1. Product breakdown size & forecasts, 2025-2035
6.5.4. Australia Tourette Syndrome Treatment Market
6.5.4.1. Product breakdown size & forecasts, 2025-2035
6.5.5. South Korea Tourette Syndrome Treatment Market
6.5.5.1. Product breakdown size & forecasts, 2025-2035
6.5.6. Rest of APAC Tourette Syndrome Treatment Market
6.5.6.1. Product breakdown size & forecasts, 2025-2035
6.6. Latin America Tourette Syndrome Treatment Market
6.6.1. Brazil Tourette Syndrome Treatment Market
6.6.1.1. Product breakdown size & forecasts, 2025-2035
6.6.2. Mexico Tourette Syndrome Treatment Market
6.6.2.1. Product breakdown size & forecasts, 2025-2035
6.7. Middle East and Africa Tourette Syndrome Treatment Market
6.7.1. UAE Tourette Syndrome Treatment Market
6.7.1.1. Product breakdown size & forecasts, 2025-2035
6.7.2. Saudi Arabia (KSA) Tourette Syndrome Treatment Market
6.7.2.1. Product breakdown size & forecasts, 2025-2035
6.7.3. South Africa Tourette Syndrome Treatment Market
6.7.3.1. Product breakdown size & forecasts, 2025-2035
Chapter 7. Competitive Intelligence
7.1. Top Market Strategies
7.2. AbbVie Inc.
7.2.1. Company Overview
7.2.2. Key Executives
7.2.3. Company Snapshot
7.2.4. Financial Performance (Subject to Data Availability)
7.2.5. Product/Services Port
7.2.6. Recent Development
7.2.7. Market Strategies
7.2.8. SWOT Analysis
7.3. Novartis AG
7.4. UCB S.A.
7.5. Teva Pharmaceutical Industries Ltd.
7.6. Acadia Pharmaceuticals Inc.
7.7. Allergan Plc.
7.8. Lundbeck A/S
7.9. Sun Pharmaceutical Industries Ltd.
7.10. Otsuka Pharmaceutical Co., Ltd.
7.11. GlaxoSmithKline Plc.
7.12. Pfizer Inc.
7.13. Bristol-Myers Squibb Company
7.14. Eli Lilly and Company
7.15. Takeda Pharmaceutical Company Limited
7.16. H. Lundbeck A/S
List of Tables
Table 1. Global Tourette Syndrome Treatment Market, Report Scope
Table 2. Global Tourette Syndrome Treatment Market Estimates & Forecasts By Region 2024–2035
Table 3. Global Tourette Syndrome Treatment Market Estimates & Forecasts By Segment 2024–2035
Table 4. Global Tourette Syndrome Treatment Market Estimates & Forecasts By Segment 2024–2035
Table 5. Global Tourette Syndrome Treatment Market Estimates & Forecasts By Segment 2024–2035
Table 6. Global Tourette Syndrome Treatment Market Estimates & Forecasts By Segment 2024–2035
Table 7. Global Tourette Syndrome Treatment Market Estimates & Forecasts By Segment 2024–2035
Table 8. U.S. Tourette Syndrome Treatment Market Estimates & Forecasts, 2024–2035
Table 9. Canada Tourette Syndrome Treatment Market Estimates & Forecasts, 2024–2035
Table 10. UK Tourette Syndrome Treatment Market Estimates & Forecasts, 2024–2035
Table 11. Germany Tourette Syndrome Treatment Market Estimates & Forecasts, 2024–2035
Table 12. France Tourette Syndrome Treatment Market Estimates & Forecasts, 2024–2035
Table 13. Spain Tourette Syndrome Treatment Market Estimates & Forecasts, 2024–2035
Table 14. Italy Tourette Syndrome Treatment Market Estimates & Forecasts, 2024–2035
Table 15. Rest Of Europe Tourette Syndrome Treatment Market Estimates & Forecasts, 2024–2035
Table 16. China Tourette Syndrome Treatment Market Estimates & Forecasts, 2024–2035
Table 17. India Tourette Syndrome Treatment Market Estimates & Forecasts, 2024–2035
Table 18. Japan Tourette Syndrome Treatment Market Estimates & Forecasts, 2024–2035
Table 19. Australia Tourette Syndrome Treatment Market Estimates & Forecasts, 2024–2035
Table 20. South Korea Tourette Syndrome Treatment Market Estimates & Forecasts, 2024–2035
………….
List of Figures
Fig 1. Global Tourette Syndrome Treatment Market, Research Methodology
Fig 2. Global Tourette Syndrome Treatment Market, Market Estimation Techniques
Fig 3. Global Market Size Estimates & Forecast Methods
Fig 4. Global Tourette Syndrome Treatment Market, Key Trends 2025
Fig 5. Global Tourette Syndrome Treatment Market, Growth Prospects 2024–2035
Fig 6. Global Tourette Syndrome Treatment Market, Porter’s Five Forces Model
Fig 7. Global Tourette Syndrome Treatment Market, Pestel Analysis
Fig 8. Global Tourette Syndrome Treatment Market, Value Chain Analysis
Fig 9. Tourette Syndrome Treatment Market By Application, 2025 & 2035
Fig 10. Tourette Syndrome Treatment Market By Segment, 2025 & 2035
Fig 11. Tourette Syndrome Treatment Market By Segment, 2025 & 2035
Fig 12. Tourette Syndrome Treatment Market By Segment, 2025 & 2035
Fig 13. Tourette Syndrome Treatment Market By Segment, 2025 & 2035
Fig 14. North America Tourette Syndrome Treatment Market, 2025 & 2035
Fig 15. Europe Tourette Syndrome Treatment Market, 2025 & 2035
Fig 16. Asia Pacific Tourette Syndrome Treatment Market, 2025 & 2035
Fig 17. Latin America Tourette Syndrome Treatment Market, 2025 & 2035
Fig 18. Middle East & Africa Tourette Syndrome Treatment Market, 2025 & 2035
Fig 19. Global Tourette Syndrome Treatment Market, Company Market Share Analysis (2025)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us